Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Venzide 37.5 Capsule XR

Prescription Icon
Prescription Required

Marketer

Emocare

Salt Composition

Venlafaxine (37.5mg)

Overview Venzide 37.5 Capsule XR

Axilon 37.5mg Extended-Release Capsules treat depression and anxiety. This medication modifies brain chemistry, alleviating anxiety symptoms like agitation, hyperactivity, poor concentration, lethargy, perspiration, tachycardia, and intrusive thoughts. Axilon 37.5mg Extended-Release Capsules should be taken with food, at the same time daily for consistent blood levels. Missed doses should be taken immediately upon recall; do not skip doses, and complete the prescribed course even with symptom improvement. Abrupt cessation is inadvisable, as it may exacerbate symptoms. Common side effects include nausea, emesis, sleep disturbances, appetite reduction, anxiety exacerbation, constipation, hyperhidrosis, and sexual dysfunction. Dizziness and somnolence may occur; avoid activities requiring alertness until the medication's effects are known. These side effects are usually transient and self-limiting. Consult your physician if symptoms persist or are bothersome. Prior to initiating Axilon 37.5mg Extended-Release Capsules, disclose any kidney, heart, or liver conditions, or history of seizures. Report any unusual mood or behavioral shifts, worsening depression, or suicidal ideation to your doctor immediately.

Uses of Venzide 37.5 Capsule XR

Mood disorders encompassing depressive and anxious symptoms

Major Benefits of Venzide 37.5 Capsule XR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and timeframe. Ingest the entire capsule; avoid chewing, crushing, or breaking it. Venzide 37.5mg Extended-Release Capsules should be administered with a meal.

Common Side effects of Venzide 37.5 Capsule XR:

  • Nausea
  • Vomiting
  • Dizziness
  • Insomnia (difficulty in sleeping)
  • Decreased appetite
  • Anxiety
  • Constipation
  • Increased sweating
  • Sexual dysfunction

How to use Venzide 37.5 Capsule XR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the capsule whole; avoid chewing, crushing, or fracturing it. It is recommended to take Venzide 37.5 mg Extended-Release Capsules with food.

How Venzide 37.5 Capsule XR works:

Extended-release Venzide 37.5mg capsules elevate brain levels of serotonin and noradrenaline, neurotransmitters crucial for emotional equilibrium.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Venzide 37.5 Capsule XR and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Venzide 37.5mg capsules might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Venzide 37.5mg capsules are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant. Close observation of infants for drowsiness and satisfactory weight increase is recommended.

DrivingDrivingUNSAFE

Driving ability may be impaired by Venzide 37.5 Capsule XR, due to potential side effects including dizziness, confusion, and visual disturbances like blurred vision.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Venzide 37.5 XR capsules; dosage modification may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Extended-release Venzide 37.5mg capsules require careful administration for individuals with hepatic impairment. Dosage modification of Venzide 37.5mg extended-release capsules may be necessary. Physician consultation is recommended.

What if you forget to take Venzide 37.5 Capsule XR :

Should you forget to take a Venzide 37.5 Capsule XR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Venzide 37.5 Capsule XR

LabelValue
Chemical Type Anisole-based compound
Developing Habits No.
Treatment Category Neuroscience of the Central Nervous System
Behavioral Class SNRIs (serotonin-norepinephrine reuptake inhibitors)

FAQs on Venzide 37.5 Capsule XR

Sedation is a possible side effect of Venzide 37.5 Capsule XR. Tell your doctor about any other sleep medications you're taking before starting this drug.
Yes. Venzide 37.5 mg Extended-Release capsules are classified as a psychotropic medication; this term encompasses any drug affecting mental state, mood, or behavior.
Venzide 37.5 XR capsules are not narcotics. Narcotics are opioid-derived drugs, such as heroin and morphine, known for their sedative effects.
Venzide 37.5 Capsule XR and ER are identical extended-release formulations. Both release medication slowly, maintaining consistent therapeutic levels. Extended-release tablets reduce the frequency of dosing.
Taking mirtazapine with Venzide 37.5 Capsule XR carries a serious risk of serotonin syndrome, a potentially life-threatening condition. Symptoms may include agitation, hallucinations, nausea, vomiting, diarrhea, rapid heart rate, fluctuating blood pressure, high fever, and coma.
Combining citalopram and venlafaxine XR (Venzide 37.5mg) is risky because both raise serotonin levels, potentially causing life-threatening serotonin syndrome. Symptoms include agitation, hallucinations, nausea, vomiting, diarrhea, rapid heart rate, fluctuating blood pressure, fever, and coma. An alternative medication should be considered.
Venzide 37.5 Capsule XR is actively removed from the brain by P-glycoprotein; however, studies indicate that both Venzide 37.5 Capsule XR and its metabolite can inhibit this transporter.
Following liver metabolism, Venzide 37.5 XR capsules are absorbed in the intestine.
Venzide 37.5 mg Extended-Release Capsules treat generalized depressive disorder. Always consult your physician before use.
Venzide 37.5 Capsule XR may cause sustained high blood pressure in some patients. Regular blood pressure monitoring is recommended for those taking this medication, with potential dose reduction or treatment discontinuation if necessary.
Constipation is a known side effect of Venzide 37.5 mg extended-release capsules in some individuals. Increase fiber intake and fluid consumption. Laxatives may also be helpful. Your doctor can advise on prevention and management. Consult your doctor if constipation persists or worsens.
Yes, Venzide 37.5 Capsule XR has been associated with weight loss in some patients, observed as dose-dependent in clinical trials. Discuss this with your doctor if concerned.
Venzide 37.5 mg extended-release capsules are not habit-forming.
Consult your doctor before substituting a tablet for a capsule; self-substitution is unsafe. Different formulations affect drug release, potentially altering treatment efficacy and causing side effects or treatment failure.
Yes, gabapentin and Venzide 37.5 XR capsules may be used together, but only under a doctor's supervision. Concurrent use can increase drowsiness, sleepiness, and impair concentration. Exercise caution.
Desvenlafaxine is the active ingredient in Venzide 37.5 Capsule XR.
Venzide 37.5 Capsule XR is not FDA-approved for fibromyalgia, although some studies suggest potential benefits. Always consult your doctor before using it for this condition.
While not FDA-approved for nerve pain, Venzide 37.5 XR capsules demonstrate efficacy in some research and are used off-label for this purpose.
Venzide 37.5 XR capsules can alter brain neurotransmitter levels, resulting in reduced appetite; this effect increases with higher doses.
Should you experience side effects such as reduced libido or impotence, consult your doctor to discuss alternative medications. Do not discontinue Venzide 37.5 Capsule XR without medical supervision; doing so may worsen side effects.
Venzide 37.5 Capsule XR
33
MRP 40
17% off